Neuropeptide Y (NPY) is a strong candidate gene for coronary artery disease (CAD). We
have previously identified genetic linkage to familial CAD in the genomic region of NPY. We …

Neuropeptide Y (NPY), a sympathetic and platelet-derived vascular mitogen and angiogenic
factor, has been implicated in atherosclerosis in animal and human genetic studies. Here we …

Objective The neuropeptide Y (NPY) signal peptide polymorphism T1128C has been linked
to several risk factors for cardiovascular disease. The aim of the present study was to …

Neuropeptide Y (NPY) is a molecule that may have both vasoconstrictive and vasodilatory
actions. A common polymorphism in the human NPY gene that results in the Leucine7 to …

With average life expectancy rising greatly, the incidence rate of arteriosclerotic
cardiovascular disease (ASCVD) has significantly increased. The heart disease has now …

Aim Neuropeptide Y is an abundantly expressed neurotransmitter capable of modulating
both immune and metabolic responses related to the development of atherosclerosis. NPY …

Leucine 7 (Leu7) to proline 7 (Pro7) substitution in the neuropeptide Y (NPY) gene has been
associated with higher serum total and low-density lipoprotein (LDL) cholesterol levels …

We have recently demonstrated that subjects having Pro7 in the signal peptide of
neuropeptide Y (NPY) have higher serum cholesterol and apolipoprotein B levels than …

AIMS: Neuropeptide Y (NPY) and Y1 receptors are involved in the mechanisms related to
the development of atherosclerosis. We investigated the effects of systemically given NPY …

Objective Neuropeptide Y affects several physiological functions, notably appetite
regulation. We analysed the association between four single nucleotide polymorphisms …